Sign in

CIK 0001468929

  • Emerging growth company

NEXGEL, INC.

Sign in to watch
Ticker
NXGL
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264042544
Phone
+1 215-702-8550
Business address
2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
Former names
NEXGEL, INC., AquaMed Technologies, Inc.

Securities

  • NXGL Common Stock Nasdaq
  • NXGLW Warrant Nasdaq
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 5,000 shares at $1.59 ($7,950)
  3. 4 Open-market buy Director bought 7,500 shares at $1.44 ($10,825)
  4. 4/A Open-market buy Director bought 7,100 shares at an average $1.18 ($8,367)
  5. 4 Open-market buy Director bought 7,100 shares at an average $1.39 ($9,868)
  6. 4 Open-market buy Director bought 5,000 shares at $1.66 ($8,280)
  7. 4 Open-market buy Director bought 1,648 shares at $1.68 ($2,769)
  8. 4 Open-market buy Director bought 5,000 shares at $1.73 ($8,650)
  9. 4 Open-market buy Director bought 5,372 shares at an average $1.85 ($9,946)
  10. 4 Open-market buy Director bought 3,128 shares at $1.60 ($4,993)
  11. 4 Open-market buy Chief Financial Officer bought 20,000 shares at an average $1.61 ($32,172)
  12. 4 Open-market buy Director bought 5,000 shares at $1.90 ($9,500)
  13. 4 Open-market buy CEO bought 1,250 shares at $1.89 ($2,360)
  14. 4 Open-market buy Director bought 5,300 shares at $1.89 ($10,010)
  15. 4 Open-market buy Director bought 5,500 shares at $1.87 ($10,285)
  16. 4 Open-market buy Director bought 9,091 shares at $5.49 ($49,910)
  17. 4 Open-market buy Director bought 1,819 shares at $5.49 ($9,986)
  18. 4 Open-market buy Director bought 28,000 shares at $5.49 ($153,720)
  19. 4 Open-market buy Director bought 9,091 shares at $5.49 ($49,910)
  20. 4 Open-market buy Director bought 5,000 shares at $5.49 ($27,450)

Page 5 of 6 · 115 filings